- Home
- OGI vs NTHI Comparison
OGI vs NTHI Comparison
Compare OGI & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | NTHI |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.5M | 195.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OGI | NTHI |
|---|---|---|
| Price | $1.79 | $8.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 63.6K |
| Earning Date | 12-16-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $186,075,713.00 | $59,990.00 |
| Revenue This Year | $20.38 | N/A |
| Revenue Next Year | $6.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.85 | $3.20 |
| 52 Week High | $2.24 | $25.00 |
Technical Indicators
Market Signals| Indicator | OGI | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 52.13 | 48.72 |
| Support Level | $1.60 | $6.40 |
| Resistance Level | $2.24 | $10.44 |
| Average True Range (ATR) | 0.18 | 0.92 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 42.00 | 51.49 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).